Mesenchymal Stem Cell Transplantation in the Treatment of Chronic Allograft Nephropathy

Summary

Mesenchymal Stem Cell (MSC) have been shown to have immunosuppressive and repairing properties. the investigators will infuse expanded MSC into patients who develop Chronic Allograft Nephropathy. The purpose of this study is to find out MSC is more effective in preventing organ rejection and maintaining kidney function.

Timeline

Start

2008-05

Primary completion

2008-05

Completion

2010-05

Drugs

Indications